[Prevalence of human papillomavirus in Spanish women from a population screening program]. / Prevalencia de virus del papiloma humano en mujeres españolas de un programa de cribado poblacionales de riesgo.

OBJECTIVE: The human papillomavirus (HPV), is necessary to cause a woman developing cervical cancer. The aim of the study was to estimate the prevalence of women with HPV infection, covered by the program of prevention and early detection of cervical cancer of Castile and León (Spain). METHODS: Samples of women included in the screening program were analyzed. Including a total of 120,326 cervical swab samples, collected in the period from January 2012 to December 2014. RESULTS: 12,183 HPV positive samples were detected, representing a prevalence of 9.6 ‰, (IC 95% 9.5%-9.8%) in the female population. High-risk HPV were found in higher proportion that HPV low-risk genotypes. HPV prevalence correlates inversely with women age. Coinfections of multiple genotypes were found in one third of screened women population. CONCLUSIONS: Data showed in this study are the first and wider Spanish results from a cervical cancer screening program population non opportunistic based on HPV detection. These results would serve as a reference for future prevalence studies and to evaluate the future impact of HPV vaccination campaigns.

Detección del VPH en mujeres con y sin alteraciones citológicas del cérvix en Castilla y León: estudio poblacional / Detection of HPV in women with no cellular alterations detected in uterine cytology in Castilla y León, population study

RESUMEN OBJETIVO: estimar la prevalencia de cambios y alteraciones cervicales en mujeres pertenecientes al Programa de Prevención y Detección Precoz de Cáncer de Cuello del Útero de Castilla y León, e identificar la coexistencia y genotipo más frecuente del VPH. MATERIALES Y MÉTODOS: estudio cuantitativo, observacional, descriptivo, transversal, retrospectivo, efectuado en mujeres de 25 a 64 años de edad que participaron en las pruebas de cribado de 2012 a 2014. Los resultados de la citología cervical convencional se interpretaron de acuerdo con la clasificación Bethesda 2001. La detección y genotipificación del VPH se realizó con PCR. Las variables cualitativas se describen mediante frecuencias absolutas y relativas (porcentajes) de sus categorías, con IC95% . Para estudiar la asociación entre variables cualitativas se utilizó la prueba de χ2. Se consideró estadísticamente significativo el valor de p≤0.05. RESULTADOS: se analizaron 190,203 muestras de frotis de cuello uterino. El 66.4% de las muestras citológicas no mostró lesiones ni alteraciones morfológicas. De las muestras citológicas con alteraciones se identificaron 7,083 con metaplasia, 2,844 con células escamosas atípicas (1.5%), 855 con lesiones de bajo grado (0.4%), 255 con lesiones de alto grado (0.13%) y 198 con lesiones cancerosas (0.1%). Las lesiones intraepiteliales de bajo y alto grado, además de los carcinomas, fueron más frecuentes en las muestras positivas a VPH (p<0.001). En relación con la atrofia vaginal de mujeres perimenopáusicas, los genotipos más frecuentes fueron el VPH-53 (0.7%), VPH-31 (0.6%) y VPH-58 (0.5%). En pacientes con lesiones intraepiteliales el genotipo más frecuente fue el VPH-16. CONCLUSIONES: la prevalencia del VPH suele ser más alta conforme aumenta la severidad de la lesión citológica detectada. El genotipo aislado con mayor frecuencia en lesiones intraepiteliales de alto o bajo grado es el VPH-16.

ABSTRACT OBJECTIVE: To estimate the prevalence of cervical changes and alterations in women belonging to the Program for the Prevention and Early Detection of Cervical Cancer of Castilla y León, and to identify the most frequent presence and genotype of Human Papilloma Virus (HVP). MATERIAL AND METHODS: A quantitative, observational, descriptive, cross-sectional, retrospective study of women aged 25-64 years who participated in screening tests during 2012 and 2014. The results of conventional cervical cytology were interpreted according with the Bethesda 2001 classification. The detection and genotyping of HPV was performed across PCR. Qualitative variables are described by absolute and relative frequencies (percentages) of their categories, with a 95% confidence interval (CI 95%). To study the association between qualitative variables, the χ2 test was used. The value of p≤0.05 was considered statistically significant. RESULTS: 190,203 samples of cervical smears were analyzed during the period. 66.4% of the cytological samples showed no lesions or morphological alterations. Of the cytological samples with alterations we identified 7,083 with metaplasia, 2,844 with atypical squamous cells (1.5%), 855 with low grade lesions (0.4%), 255 with high grade lesions (0.13%) and 198 with cancerous lesions%). Low- and high-grade intraepithelial lesions, in addition to carcinomas, were more frequent in HPV positive samples (p <0.001). To the vaginal atrophy of perimenopausal women we detected HPV-53 (0.7%), HPV-31 (0.6%) and HPV-58 (0.5%) genotypes. In patients with intraepithelial lesions the most frequent genotype was HPV-16. CONCLUSIONS: the prevalence of HPV is usually higher according to the severity of the cytological lesion detected. The most frequently isolated genotype in high-grade low-grade intraepithelial lesions is HPV-16.

Protein determination in serum and whole blood by attenuated total reflectance infrared spectroscopy.

Attenuated total reflectance mid-infrared spectra of serum and blood samples were obtained from 4,000 to 600 cm(-1). Models for the determination of albumin, immunoglobulin, total globulin, and albumin/globulin coefficients were established for serum samples, using reference data obtained by capillary electrophoresis. Based on the use of the amide bands I and II regions, the relative root mean square error of prediction (RRMSEP) was 4.9, 14.9, 4.5, and 7.1% for albumin, immunoglobulin, total globulin, and albumin/globulin coefficients, respectively, determined in an independent validation set of 120 samples using 200 samples for calibration. Additionally, the use of Kennard-Stone method for the selection of a representative calibration subset of samples provided comparable results using only 60 samples. For whole blood analysis, hemoglobin was determined in 40 validation samples using models built from 40 calibration independent samples with RRMSEP of 8.3, 5.5, and 4.9% with models built from direct spectra in the first case and from sample spectra recorded after lysis by sodium dodecyl sulfate and freezing, respectively, for the last two ones. The developed methodologies offer green alternatives for patient diagnosis in a few minutes, minimizing the use of reagents and residues and being adaptable for its use as a point-of-care method.

Tumor mixto maligno mamario / Breast malignant mixed tumor

No disponible